Author (Corporate) |
European Commission |
Series Title |
COM
|
Series Details |
(2008) 662 final (21.10.08)
|
Publication Date |
21/10/2008 |
Content Type |
Policy-making |
Source Link |
Link to Main Source
http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=COM:2008:0662:FIN:EN:PDF
|
Related Links |
-
European Commission: SEC(2008)2667: Impact assessment
http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=SEC:2008:2667:FIN:EN:PDF
-
European Commission: SEC(2008)2668: Summary of the impact assessment
http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=SEC:2008:2668:FIN:EN:PDF
-
European Commission: COM(2008)663: Proposal for a Directive of the European Parliament and of the Council amending, as regards information to the general public on medicinal products subject to medical prescription, Directive 2001/83/EC on the Community code relating to medicinal products for human use
http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=COM:2008:0663:FIN:EN:PDF
-
EUR-Lex: COM (2008)662: Follow the progress of this document through the decision-making procedure
http://eur-lex.europa.eu/legal-content/EN/HIS/?uri=COM:2008:662:FIN
|
Subject Categories |
Business and Industry, Health
|
Countries / Regions |
Europe |